Clinical Trial Update: New CVD Risk Factors for Lowered Cognitive Functioning

View source ↗

Summary

An NHLBI-sponsored trial update reports newly identified cardiovascular risk factors associated with lowered cognitive functioning; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Cognitive Impairment
• Hypertension

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED